• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

New Respiratory Business Model

















Normally I would think we were safe since they just spent all that money on the POA but who knows with these dip shits. They could be finally closing down the division: